(PharmaNewsWire.Com, September 07, 2021 ) According to the new market research report "Medical Electrodes Market by Product [Diagnostic Electrodes (ECG, EEG, EMG), Therapeutic Electrodes (Defibrillator, Pacemaker)], Technology (Wet, Dry, Needle), Application (Neurophysiology, IOM), Usage (Disposable, Reusable), - Global Forecast to 2026", published by MarketsandMarkets™, is projected to reach USD 2.1 billion by 2026 from USD 1.7 billion in 2021, at a CAGR of 4.3% during the forecast period.
Browse in-depth TOC on "Medical Electrodes Market"
The Growth in the medical electrodes market is primarily driven by factors such as the rising incidence of target diseases, increasing investments in research, and growing preference for home and ambulatory healthcare services.
In 2020, ECG electrodes accounted for the largest share of the market and is also expected to grow at the highest CAGR during the forecast period.
Based on the type, the diagnostic medical electrodes market is segmented into electrocardiography (ECG) electrodes, electroencephalography (EEG) electrodes, electromyography (EMG) electrodes, and other diagnostic electrodes [electroretinography (ERG) and electrooculography (EOG)]. Among these, the ECG segment accounted for the largest share of the diagnostic market in 2020. The large share of this segment can be attributed to the rising prevalence of CVD, increasing incidence of arrhythmias, and technological advancements in ECG electrodes.
The defibrillator electrodes segment is expected to grow at the highest CAGR during the forecast period and also accounted for the largest share in 2020.
Based on type, therapeutic medical electrodes are segmented into defibrillator electrodes, electrosurgical electrodes, transcutaneous electrical nerve stimulation (TENS) electrodes, pacemaker electrodes, neuromuscular stimulation electrodes (NMES), and other therapeutic medical electrodes (wound healing electrodes, blood gas electrodes, and iontophoresis electrodes). The defibrillator electrodes segment accounted for the largest share of the therapeutic medical electrodes market in 2020 and is expected to grow at the highest CAGR during the forecast period. This is attributed to factors such as rising incidence of cardiovascular diseases (CVD) coupled with the growing geriatric population across the globe.
North America was the largest regional market for the medical electrodes market in 2020
The medical electrodes systems market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is the largest market for medical electrodes in 2020. Factors such as the high prevalence of cardiac and neurological diseases and increasing product innovation in the region are driving the growth of the North American market. However, the Asia Pacific market is estimated to grow at a higher CAGR of during the forecast period. Growth in the Asia Pacific market is primarily attributed to the rising prevalence of cardiac and neurological diseases, growth in the aging population, rising adoption of advanced technologies, and the growing focus of major players on enhancing their presence in emerging Asia Pacific countries.
The global medical electrodes market is fragmented. The prominent players operating in this market include Medtronic (Ireland), Ambu A/S (Denmark), 3M (US), Natus Medical Incorporated (US), Koninklijke Philips N.V. (Netherlands), B. Braun Melsungen AG (Germany), ZOLL Medical Corporation (US), Cardinal Health (US), CONMED Corporation (US), Nihon Kohden Corporation (Japan), Rhythmlink International, LLC (US), Cognionics, Inc. (US), GE Healthcare (US), Compumedics Limited (Australia), and Nissha Medical Technologies (Japan).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: